Clinical Trial Update: Pain Assessment and Quality of Life in Back Pain Patients: Role of Milnacipran [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating milnacipran for back pain has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Back Pain

Drugs mentioned

• SAVELLA (milnacipran hydrochloride)

Snippet

Sponsor: Brigham and Women's Hospital | Conditions: Back Pain | Phase 3 | Status: WITHDRAWN